Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Diabetes
Do you recommend up-titrating the Metformin dose of patients with T2DM who are at goal A1c in order to decrease their risk of diabetes-related delirium?
Sun et al., PMID 39361020
Answer from: at Academic Institution
I have not been adjusting metformin based on delirium.
Sign In
or
Register
to read more
28157
Related Questions
After what time frame off GLP-1 RA therapy should you restart at the lowest starting dose?
When would you consider switching a patient with insulin-requiring Type 2 DM to an automated insulin delivery system?
Do you typically adjust pump settings for patients with diabetes who are on automated insulin pumps and fasting all day for religious reasons such as Ramadan?
What are your thoughts on trending beta-hydroxybutyrate once a diagnosis of DKA is already established?
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
Do you recommend routinely monitoring pancreatic markers such as amylase and lipase while receiving GLP1 R agonist or dual agonist therapies to determine their risk of pancreatitis?
In patients using a tandem insulin pump on auto-mode/Control-IQ, would decreasing the basal settings on the profile actually reduce the delivered hourly insulin dose or is that only relevant if they switch to manual mode?
How should diabetic retinopathy surveillance be adjusted for patients starting GLP-1 agonists?
How many days prior to elective major surgery do you recommend holding oral GLP 1 R agonist therapy?
Do you avoid the use of GLP-1 R agonist therapy for treatment of obesity in patients with known gastroparesis?